Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3.
The two organic anion transporting polypeptides (OATPs) 1B1 and 1B3 are expressed at the sinusoidal membrane of hepatocytes. They have a broad and overlapping substrate specificity and transport many endobiotics and drugs. Specific inhibitors are required to determine the contribution of each OATP to the hepatocellular uptake of common substrates. We have developed a cell-based high-throughput assay to screen chemical libraries in order to identify such inhibitors for OATP1B1 and OATP1B3. We have used OATP1B1- or OATP1B3-expressing Chinese Hamster Ovary cells on 96-well plates and determined uptake of fluorescein-methotrexate (FMTX). We validated the assay with known inhibitors and screened the well characterized Prestwick library of 1120 drugs. Along with several known OATP inhibitors including rifampicin, cyclosporine A and mifepristone we identified some new inhibitors. For inhibitors that seemed to be able to distinguish between OATP1B1- and OATP1B3-mediated FMTX uptake IC(50) values were determined. Estropipate (estrone-3-sulfate stabilized with piperazine) was the most selective OATP1B1 inhibitor (IC(50) = 0.06 microM vs. 19.3 microM for OATP1B3). Ursolic acid was the most selective OATP1B3 inhibitor (IC(50) = 2.3 microM vs. 12.5 microM for OATP1B1). In conclusion, this cell-based assay should allow us to identify even more specific inhibitors by screening larger chemical libraries.
Gui
Chunshan
C
Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Obaidat
Amanda
A
Chaguturu
Rathnam
R
Hagenbuch
Bruno
B
Mol Pharmacol. 2001 Nov;60(5):934-43
11641421
Hepatology. 2002 Jul;36(1):164-72
12085361
Drug Metab Dispos. 2008 Apr;36(4):663-9
18180276
Xenobiotica. 2008 Jul;38(7-8):778-801
18668430
Gastroenterology. 2006 May;130(6):1793-806
16697742
Diabetes. 2008 Jun;57(6):1463-9
18314419
Mol Pharmacol. 2005 Oct;68(4):1031-8
16046661
Gastroenterology. 2001 Jun;120(7):1689-99
11375950
Eur J Pharmacol. 2008 Apr 14;584(1):57-65
18321482
Drug Metab Dispos. 2007 Aug;35(8):1400-7
17496208
J Biol Chem. 1999 Jun 11;274(24):17159-63
10358072
Gastroenterology. 2001 Nov;121(5):1185-90
11677211
J Lipid Res. 2006 Jun;47(6):1196-202
16534140
Gastroenterology. 2001 Feb;120(2):525-33
11159893
Drug Metab Dispos. 2006 Jul;34(7):1229-36
16595711
Drug Metab Dispos. 2006 May;34(5):862-9
16501004
Am J Physiol. 1999 Apr;276(4):G1037-42
10198348
Pflugers Arch. 2004 Feb;447(5):653-65
14579113
Hepatology. 1996 Aug;24(2):380-4
8690408
Protein Expr Purif. 2006 Jun;47(2):591-8
16481201
Eur J Pharm Biopharm. 2006 Jan;62(1):39-43
16129589
Drug Metab Dispos. 2006 Jul;34(7):1247-54
16624871
Drug Metab Pharmacokinet. 2008;23(5):347-55
18974612
J Pharmacol Exp Ther. 2003 Jan;304(1):223-8
12490595
J Biol Chem. 2001 Mar 30;276(13):9626-30
11134001
Mol Pharmacol. 2006 Nov;70(5):1735-41
16908597
J Pharmacol Exp Ther. 2004 Oct;311(1):139-46
15159445